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Previous studies reported that subcutane-
ous administration of 2,3,7,8-tetrachlorodi-
benzo-p-dioxin (TCDD) at a dose level of 3
,pg/kg, in mice on days 6 through 15 of ges-
tation produced pups with cleft palates and
kidney anomalies (1). The C57B1/6 mouse
was the most sensitive of the three strains
tested to the TCDD-induced kidney effects,
in that almost 100%o of the fetuses developed
kidney anomalies. The purpose of this pa-
per is to report subsequent studies which
attempt to characterize the teratogenic re-
sponse as seen in the C57B1/6 mouse with
specific emphasis on the nature and signifi-
cance of the kidney anomaly. To distinguish
between delayed kidney development, which
if transient is of diminished significance,
and irreversible effects, postnatal studies
were also conducted. Reversible delays in
metanephric kidney maturation in the rat
have been described (2).
Materials and Methods
Inbred mice of the C57B1/6 strain were
obtained from either the Jackson Laboratory,
Bar Harbor, Maine, or the AR Schmidt Com-
pany, Madison, Wisconsin, and mated at the
Institute. Detection of a vaginal plug indi-
cated day 0 of pregnancy. All experimental
mice were singly housed in plastic cages and
allowed free access to food and water.
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The 2,3,7,8-tetrachlorodibenzo-p-dioxin
(>99%0 purity, Dow Chemical Company,
Midland, Michigan) was dissolved in ace-
tone and subsequently diluted with at least
9 parts of corn oil. All mice were weighed
prior to dosing, and the oral dose adminis-
tered computed on the mean weight of the
mice being treated. Control mice received
an equivalent amount of 0.1 ml of an ace-
tone-corn oil preparation.
Fetuses were removed from their mother
on gestation day 18 and necropsied after
fixation in Bouins solution. Mice necropsied
in the postnatal studies were processed ac-
cording to standard necropsy procedures.
Tissues for histologic examination were fixed
in either Bouins or 10%o neutral buffered
formalin, paraffin embedded and stained
with hematoxylin and eosin. The incidence
of an abnormality is given as mean average
percent which is derived by determining its
percent incidence in a litter and subse-
quently computing the mean of these per-
cents.
Results
The effects of maternal treatment with
TCDD on fetal palate closure and kidney
development are shown in Table 1. TCDD at
3 pg/kg, administered on gestation days 10
through 13, produced cleft palate in pups
from 12 of 14 litters with a mean average
incidence of 55.4%o. The mean average kid-
ney and bilateral kidney incidence was
95.1 o and 83.1%o, respectively, with all lit-
September 1973 81ters affected. When the dose of TCDD ad-
ministered on gestation days 10 through 13
was reduced to 1 jug/kg, cleft palate inci-
dence decreased to a mean of 1.9%'o. The
litter incidence of kidney anomalies per-
sisted at high levels; unilateral mean aver-
age pup incidence decreased to 58.9%o and
the corresponding figure for bilateral effect
decreased to 36.3%o. When TCDD adminis-
tration at 1 ug/kg was a single dose admin-
istered on gestation day 10, no cleft palates
were produced. The average mean incidence
of unilateral kidney effects was 34.39 with
anomalies occurring in 16 of 18 litters. Bi-
lateral kidney effects at this dose occurred in
seven litters with a mean incidence of 8.8%b.
No cleft palates or kidney anomalies oc-
curred in controls.
The fetal kidney anomaly is best de-
scribed as a renal papilla which is markedly
reduced in size, or nonexistent in a few
cases, resulting in an enlarged renal pelvis
(Fig. 1). Given the stage of kidney develop-
ment this may reflect a retardation or ab-
sence of papillae development rather than
loss of an already formed structure. Nephron
development appears similar to that occur-
ring in control mice of the same age. The
appearance of the affected kidneys resemble
an early stage of hydronephrosis. It was fur-
ther noted that when the renal anomalies
were unilateral, the right kidney was af-
fected 70.5%o of the time. This preponder-
ance of right kidney involvement had a high
statistical significance (P<0.01).
FIGURE 1. Transverse section of a hydronephrotic
kidney from an 18-day-old C57B1/6 fetus whose
mother received 3 pg/kg TCDD on gestation days
10-13.
To assess the impact of this kidney change
on the ability of a pup to survive in an
extrauterine environment, postnatal studies
were conducted. Pregnant C57B1/6 mice re-
ceived 1 jug/kg TCDD on gestation day 10
and were allowed to litter. In one study lit-
ters from TCDD-treated mothers were fos-
Table 1. Incidence of cleft palate and kidney anomalies in C57B1/6 fetuses from
TCDD-treated mothers.a
Bilateral
Cleft palate Kidney anomalies kidney anomalies
TCDD No. Mean No. Mean No. Mean
dose, No. affected average affected average affected average
Treatment days /Ag/kg litters litters % litters % litters %
10-13 3 14 12 55.4 14 95.1 14 83.1
10-13 1 16 3 1.9 15 58.9 13 36.3
10 1 18 0 0 16 34.3 7 8.8
10, 10-13 0 27 0 0 0 0 0 0
* No significant differences in the number of live fetuses, resorptions, fetal weight and maternal weight
was found at these dose levels when compared to controls.
Environmental Health Perspectives 82tered on control mothers; litters from con-
trol mice nursed TCDD treated mice. To
distinguish a prenatal effect from a post-
natal effect or from a combined prenatal
and postnatal effect, a reciprocal cross fos-
tering study was conducted. The results of
these studies as they affected kidney are de-
picted in Table 2. It was found that only one
pup from a TCDD-treated mother, who
nursed an untreated mother, had kidney
lesions when necropsied on postnatal day 14.
A total of six pups, in four of the 14 litters,
who nursed TCDD mothers but were born
of untreated mothers had hydronephrotic
kidneys. In the four-way cross foster study,
almost all kidney lesions occurred in pups
whose mother received 1 ,tg/kg TCDD and
subsequently nursed a TCDD treated
mother. Five of 7 litters contained pups with
hydronephrotic kidneys with a mean aver-
age pup incidence of 34%. Almost one half
of the affected pups had both kidneys af-
fected. Three pups in two litters, from un-
treated mothers who nursed a TCDD-treated
mother, also had kidney anomalies; one was
bilaterally involved. One pup from a TCCD-
treated female which nursed an untreated
mother had an affected kidney, as did one of
the control pups.
To confirm that exposure to TCDD-treated
females during the nursing period was a
major factor in development of renal hy-
dronephrosis in mouse pups, experiments
where mothers were treated on the day of
parturition were conducted. In these studies,
mice received 0, 1, 3 or 10 pg/kg at parturi-
tion developed hydronephrosis. A mean
average of 75% of the pups developed at
least unilateral hydronephrosis; a mean
average of 40% developed bilateral hydro-
nephrosis. At the 3 1ug/kg dose, a mean aver-
age of 71% of pups in three of three litters
developed a right unilateral hydronephrosis.
At the 1 ug/kg dose level, a mean average of
12%b of pups in five of nine litters developed
a unilatteral hydronephrosis.
Gross and histological studies of affected
mice reveal that the lesion produced is a
progressive hydronephrosis. Essentially,
total atrophy of the right kidney had oc-
curred in several 55-day-old mice which had
nursed a female that received 10 ug/kg
TCDD at parturition (Fig. 2). There were
FIGURE 2. Gross photograph of kidneys from 55-day-
old C57B1/6 mice: (top row) left and right kid-
neys from mice who nursed a control mother.
(bottom row) kidneys from mice who nursed a
mother treated with 10 /ag/kg TCDD. Left kidney
enlarged and fluid-filled. Right kidneys with
marked hydronephrosis and complete atrophy of
renal parenchyma (lower right).
Table 2. Incidence of hydronephrosis in C57B1/6 mouse pups following exposure to
TCDD; mice treated at 1 ,.g/kg on day 10 of pregnancy.'
Period exposed to Kidney hydronephrosis Bilateral hydronephrosis
TCDD mother No. Mean No. Mean
No. affected average affected average In utero Postnatal litters litters % litters to
Yes No 14 1 2.0 0 0
No Yes 14 4 9.6 1 0.8
Yes Yes 7 5 34.Q 4 17.0
Yes No 5 1 2.2 0 0
No Yes 5 2 7.4 1 0.5
No No 7 1 1.7 0 0
a No significant differences in pup weight, maternal weight or litter mortality was observed.
September 1973 83never any indications of a hydroureter ac-
companying the hydronephrosis. Serial sec-
tions of some renal pelves at the site of ure-
ter entrance did not indicate a lack of
patency. Serial sections at the site of ureter
insertion into the bladder also indicated that
there was no blockage. There is a weak im-
pression that the ureter associated with a
hydronephrotic kidney has a lumen of small-
er diameter and that there may be a slight
thickening or increase in the epithelial cells
of the ureter mucosa. In those mice in which
unilateral renal hydronephrosis occurred, the
right kidney was affected over 90%o of the
time. The tendency for unilateral hydroneph-
rosis to involve the right kidney suggests an
anatomical variation which predisposes its
involvement at low dose levels. The right
kidney in mice is normally superior in posi-
tion; the vena cava, due to its close proximity
to the right kidney, provides less room for
ureter insertion into the kidney hilus.
Whether these anatomical characteristics con-
tribute to this curious pattern of incidence
remains a moot point.
Failure to mention possible thymus effects
in a paper dealing with TCDD exposure
would be misleading. Unfortunately, data
are too meager and diverse in source to
assemble specific figures for presentation;
however, there appears to be a reduction in
thymus weight at birth in some pups from
females treated with TCDD during preg-
nancy. In postnatal studies, there was a
dose-related thymus weight decrease when
compared to controls in pups weaned from
mothers who received 10 or 3 pg/kg TCDD
at parturition. Definitive experiments to
assess thymic effect and possible impair-
ment of cellular immunity are planned.
Discussion
The results of these studies clearly indi-
cate that exposing pregnant mice to TCDD
during the period when progeny are under-
going metanephric kidney formation or
maturation leads to the development of hyd-
ronephrosis. The incidence of this defect
shows a dose-response relationship as scored
by the litter, mean average pup, and uni-
lateral or bilateral kidney incidence. Associa-
tion with a treated mother during the nurs-
ing period accounted for the highest inci-
dence of hydronephrosis in the studies de-
scribed. Pups probably are being exposed to
TCDD by its presence in milk.
The postnatal studies subsequent to pre-
natal exposure to TCDD at gestation day 10
would seem on first examination to discredit
the significance of kidney anomalies re-
corded from fetuses examined on gestation
day 18. However, a comparison of the salient
features of the prenatal and postnatal kid-
ney effects reveals striking similarities: (1)
the lesion in both cases is best described as
a hydronephrosis; (2) there is a similar
dose-response relationship of kidney effects;
(3) there is a tendency for right kidney
hydronephrosis at low TCDD doses. The
failure to demonstrate progressive hydron-
ephrosis postnatally in pups exposed only
in utero is likely a function of dose and
Table 3. Hydronephrosis in C57B1/6 pups from mothers treated with TCDD at
parturition.a
Kidney hydronephrosis Bilateral hydronephrosis
TCDD No. Mean No. Mean
dose, No. Average no. affected average affected average
,ug/kg litters pups/litter litters % litters %
0 4 6 0 0 0 0
10 5 6 5 75 3 40
0 4 6 0 0 0 0
3 3 5.3 3 71 0 0
0 8 8.0 0 0 0 0
1 9 7.7 5 12 0 0
a Pups nursing mothers treated with 10 ,ug/kg TCDD were reduced in size at weaning.
Environmental Health Perspectives 84length of target organ exposure. This con-
clusion is supported by the findings that the
greatest incidence of hydronephrosis oc-
curred in those litters which were exposure
to TCDD both in utero and during the post-
natal period. It is hypothesized that the
pathogenesis of the hydronephrotic syn-
drome due to prenatal or postnatal maternal
exposure is similar. Studies which test this
hypothesis are in progress.
Summary
Hydronephrotic kidneys were produced in
mouse pups that nursed a mother treated
with TCDD during pregnancy or at time of
parturition. Variations in kidney develop-
ment, consistent with hydronephrosis, were
observed in fetuses examined at gestation
day 18. It was hypothesized that the pre-
natal and postnatal kidney anomaly are of
the common etiology and that the incidence
and degree of hydronephrosis is a function
of dose and length of target organ exposure.
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